physcione has been researched along with genistein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
| Matsuda, H; Morikawa, T; Shimoda, H; Yoshikawa, M | 1 |
| Adepally, U; Banothu, V; Chakrabarti, S; Kumar, K; Luthra, T; M, S; Maddi, SR; Sen, S | 1 |
1 review(s) available for physcione and genistein
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |
2 other study(ies) available for physcione and genistein
| Article | Year |
|---|---|
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
Topics: Anthraquinones; Cell Division; Cells, Cultured; Emodin; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Genistein; Humans; Isoflavones; Phytoestrogens; Plant Preparations; Polygonaceae; Protein Binding; Receptors, Estrogen; Structure-Activity Relationship | 2001 |
Discovery of novel pyrido-pyrrolidine hybrid compounds as alpha-glucosidase inhibitors and alternative agent for control of type 1 diabetes.
Topics: alpha-Glucosidases; Animals; Binding Sites; Blood Proteins; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Drug Discovery; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Male; Mice; Molecular Docking Simulation; Molecular Structure; Pyrrolidines; Rats; Rats, Sprague-Dawley; Solubility; Streptozocin; Structure-Activity Relationship; Thermodynamics | 2020 |